Clinical studies recruiting near Lincoln

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia
Phase 3 · Vanda Investigational Site · Vanda Pharmaceuticals · NCT06953869 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Cancer Partners of Nebraska · Pfizer · NCT06758401 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · NHO Revive Research Institute · Hoffmann-La Roche · NCT06793215 A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Au
Phase 3 · Local Institution - 0147 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT07424404 Randomization of Single vs Multiple Arterial Grafts
NA · Nebraska Heart Hospital · Weill Medical College of Cornell University · NCT03217006 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Bryan Heart · Amgen · NCT07037433 Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832 An Evaluation of an Online Sexual Assault Resistance Program (IDEA3)
NA · University of Nebraska - Lincoln · University of Maryland, College Park · NCT06058455 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · NHO Revive Research Institute, LLC ( Site 4009) · Merck Sharp & Dohme LLC · NCT06077760 Association of Periodontal Inflammation on Immune Response in Wound Healing
Phase N/A · University of Nebraska, College of Dentistry · University of Nebraska · NCT04805320 A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in Fi
Phase 3 · Cancer Partners of Nebraska · Amgen · NCT07005128 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Saint Elizabeth Regional Medical Center · NRG Oncology · NCT05174169 A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Phase 2 · NHO Revive Research Institute, LLC ( Site 0137) · Merck Sharp & Dohme LLC · NCT06833073 Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing
NA · Bryan Heart · University of British Columbia · NCT04634240 A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the Knee
Phase 2 · Physicians Research Collaboration · Pacira Pharmaceuticals, Inc · NCT06884865 Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I
Phase 3 · Alkermes Investigator Site · Alkermes, Inc. · NCT05303064 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · Nebraska Hematology Oncology /ID# 257710 · AbbVie · NCT04928846 Study of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adults With Birch Pollen Allergy
Phase 3 · Somnos Clinical Research · Regeneron Pharmaceuticals · NCT07309432 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06692738 Investigating the Effects of Beef Consumption on Cognitive and Brain Health
NA · University of Nebraska-Lincoln · University of Nebraska Lincoln · NCT06690892 This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate
Phase N/A · Allergy Asthma & Immunology- Site Number : 8400044 · Sanofi · NCT07290803 A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-
Phase 2 · NHO Revive Research Institute, LLC ( Site 0121) · Merck Sharp & Dohme LLC · NCT06890884 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · Saint Elizabeth Regional Medical Center · National Cancer Institute (NCI) · NCT04269902 BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer
Phase 3 · Cancer Partners of Nebraska April Sampson Cancer Center · BeOne Medicines · NCT07492641 Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · Atrium Health Lincoln/LCI-Lincolnton · Canadian Cancer Trials Group · NCT06592924 A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H
Phase 2/Phase 3 · Bryan Health Pine Lake Campus /ID# 259638 · AbbVie · NCT06345339 A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
Phase 2 · Physician Research Collaboration, LLC ( Site 0057) · Merck Sharp & Dohme LLC · NCT07133633 Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene M
Phase 2 · Saint Elizabeth Regional Medical Center · SWOG Cancer Research Network · NCT05806515 Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
Phase N/A · Home-based telemedicine · Ensoma · NCT06605378

Look up another city

Look up another condition